Published in Int J Endocrinol on June 19, 2014
Comparison of Two ELISA Methods and Mass Spectrometry for Measurement of Vitamin D-Binding Protein: Implications for the Assessment of Bioavailable Vitamin D Concentrations Across Genotypes. J Bone Miner Res (2016) 0.89
Association between serum 25-hydroxyvitamin D levels and carotid atherosclerosis in chronic kidney disease patients. BMC Nephrol (2016) 0.75
Measurement of circulating 25-hydroxyvitamin D: A historical review. Pract Lab Med (2015) 0.75
Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxyvitamin D3. Significance of the free 1,25-dihydroxyvitamin D3 concentration. J Clin Invest (1981) 3.15
Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Acta (2006) 2.97
Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis (2005) 2.82
Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int (2009) 2.52
Roadmap for harmonization of clinical laboratory measurement procedures. Clin Chem (2011) 2.34
Editorial: The determination of circulating 25-hydroxyvitamin D: no easy task. J Clin Endocrinol Metab (2004) 2.24
Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol (2004) 2.21
Measurement of 25-hydroxyvitamin D in the clinical laboratory: current procedures, performance characteristics and limitations. Steroids (2010) 2.19
Vitamin D status as an international issue: national surveys and the problem of standardization. Scand J Clin Lab Invest Suppl (2012) 2.01
Accuracy of 25-hydroxyvitamin D assays: confronting the issues. Curr Drug Targets (2011) 1.87
The measurement of the vitamin D-binding protein in human serum. J Clin Endocrinol Metab (1977) 1.73
Candidate reference measurement procedures for serum 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 by using isotope-dilution liquid chromatography-tandem mass spectrometry. Clin Chem (2011) 1.62
Radioimmunoassay of the binding protein for vitamin D and its metabolites in human serum: concentrations in normal subjects and patients with disorders of mineral homeostasis. J Clin Invest (1976) 1.56
Accuracy of 6 routine 25-hydroxyvitamin D assays: influence of vitamin D binding protein concentration. Clin Chem (2012) 1.44
Enhanced excretion of vitamin D binding protein in type 1 diabetes: a role in vitamin D deficiency? J Clin Endocrinol Metab (2010) 1.35
Comparison of equilibrium and disequilibrium assay conditions for ergocalciferol, cholecalciferol and their major metabolites. J Steroid Biochem (1984) 1.33
Vitamin D binding protein (Gc-globulin). Endocr Rev (1989) 1.25
Vitamin D and chronic kidney disease. Ethn Dis (2009) 1.20
Vitamin D and kidney disease. Clin J Am Soc Nephrol (2008) 1.16
Proficiency testing of 25-hydroxyvitamin D (25-OHD) assays. J Steroid Biochem Mol Biol (2010) 1.06
Standardization of measurements of 25-hydroxyvitamin D3 and D2. Scand J Clin Lab Invest Suppl (2012) 1.03
Turnover of the plasma binding protein for vitamin D and its metabolites in normal human subjects. J Clin Endocrinol Metab (1981) 0.93
Relationship between free and total 1,25-dihydroxyvitamin D in conditions of modified binding. Eur J Endocrinol (2001) 0.90
High-performance liquid chromatographic assay for 25-hydroxyvitamin D3 in serum. Clin Chem (1977) 0.80
A simple radioassay for 25-hydroxycholecalciferol without chromatography. Clin Chim Acta (1976) 0.77